TDOC
Teladoc Health, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +24.8% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 88.23K | $488,810 | n/a | −2 |
| Q2 2026 | 111 | +6 | 112.96M | $926.27M | +10 | −5 |
| Q1 2026 | 109 | +2 | 103.34M | $549.43M | +5 | −3 |
| Q4 2025 | 106 | -1 | 112.74M | $760.88M | n/a | −1 |
| Q3 2025 | 19 | +1 | 71.06M | $549.33M | +2 | −2 |
| Q2 2025 | 16 | -1 | 66.90M | $582.70M | n/a | −1 |
| Q1 2025 | 14 | +1 | 30.12M | $239.71M | +1 | n/a |
| Q4 2024 | 13 | 0 | 34.32M | $311.99M | +2 | −2 |
| Q3 2024 | 12 | -1 | 22.43M | $205.74M | +1 | −2 |
| Q2 2024 | 13 | n/a | 27.83M | $272.20M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 11.18M | +33.6% | $101.62M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 5.67M | +15.5% | $51.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 5.08M | n/a | $46.18M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | Geode Capital Management ✦ (passive) | 3.95M | +0.6% | $35.89M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 3.14M | -1.9% | $28.52M | 0.0% | ▼ Trim | 3 | SEC ↗ ×7 |
| 6 | Two Sigma Investments ✦ | 2.02M | New | $18.35M | 0.0% | New | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 1.38M | +399.2% | $12.50M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 981.80K | +60.2% | $8.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 373.26K | -18.7% | $3.39M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 10 | D. E. Shaw & Co. ✦ | 207.00K | +282.8% | $1.88M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 11 | Norges Bank ✦ (passive) | 178.00K | New | $1.62M | 0.0% | New | 1 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 138.69K | +13.0% | $1.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 28.88K | -74.4% | $262,483 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $18.35M | 0.0% |
| Norges Bank | $1.62M | 0.0% |
Exited
| Marshall Wace | $3.62M | was 0.0% |
| ARK Investment Management | $0 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 250.00K shares, $1,362 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 655 sh · $3,703
Officer, Director · 17.80K sh · $108,682
Officer · 7.36K sh · $46,356
Officer, Director · 18.33K sh · $115,478
Officer · 274 sh · $1,726
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology